Mannatech (NASDAQ:MTEX) Now Covered by Analysts at StockNews.com

Equities research analysts at StockNews.com began coverage on shares of Mannatech (NASDAQ:MTEX) in a research report issued to clients and investors on Thursday. The brokerage set a “buy” rating on the stock.

Mannatech Stock Down 11.5 %

MTEX stock opened at $10.43 on Thursday. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.25 and a quick ratio of 0.74. The firm has a market capitalization of $19.61 million, a P/E ratio of -12.88 and a beta of 1.18. Mannatech has a 52-week low of $6.75 and a 52-week high of $13.00. The company’s 50 day simple moving average is $8.55 and its 200-day simple moving average is $7.79.

Mannatech (NASDAQ:MTEX) last posted its quarterly earnings data on Tuesday, November 12th. The company reported ($0.17) earnings per share for the quarter. The firm had revenue of $31.73 million for the quarter. Mannatech had a negative return on equity of 15.62% and a negative net margin of 1.26%.

Mannatech Company Profile

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.